Finding the courage to reconsider medical therapy for stable angina

New England Journal of Medicine

Volumn 359, Issue 7, 2008, Pages 751-753

  Peterson, Eric D ^a   Rumsfeld, John S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE COURSE; EDITORIAL; HEART INFARCTION; HUMAN; MORTALITY; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUALITY OF LIFE; REVASCULARIZATION; RISK FACTOR; SCORING SYSTEM; STABLE ANGINA PECTORIS; STRUCTURED QUESTIONNAIRE; TREATMENT RESPONSE;

ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; COMBINED MODALITY THERAPY; CORONARY DISEASE; HEALTH STATUS; HUMANS;

EID: 49449101259     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0804662     Document Type: Editorial

References (7)

1. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.
2. Future PCI/stent use among stable angina patients could depend on COURAGE: managed care first report. (Accessed July 25, 2008, at http://www.mccfirstreport.com/show_story.php?newsid=1172.)
3. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008;359:677-87.
4. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41.
5. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med 2001;33:350-7.
6. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.
7. ACC NCDR data. Durham, NC: Duke Clinical Research Institute, 2008.